Document is current
Any future updates will be listed below
-
Authors
Knudsen, Erik S. https://orcid.org/0000-0002-5130-5969
Witkiewicz, Agnieszka K. https://orcid.org/0000-0003-4538-1145
Kabraji, Sheheryar https://orcid.org/0000-0002-5315-7103
- License Information
-
More Information
Article History
Accepted: 25 March 2026
First Online: 27 April 2026
Competing interests
: E.S.K.: sponsored research funding from Bristol Myers Squibb and Blueprint Medicines; consulting activities through Cancer Cell Cycles-LLC. A.K.W.: sponsored research funding from Bristol Myers Squibb, Aleksia Therapeutics and Blueprint Medicines. S.K.: consulting for Daiichi–Sankyo, Gilead and AstraZeneca; speaking engagements with OncLive, Curio-Science and Dava Oncology.
